25th Polish Conference on Biocybernetics and Biomedical Engineering

Maria Chatzinikolaidou, FBSE, FTERM, FIAMBE, is a Professor of Biomaterials in Bioengineering and Head of the Laboratory for Biomaterials in Tissue Engineering at the Department of Materials Science and Engineering at the University of Crete, and affiliated faculty member at the Foundation for Research and Technology-Hellas FORTH (ORCID: https://orcid.org/0000-0002-2749-2506). She received her B.Sc. in Chemistry from the University of Essen, Germany and her doctoral degree in Biochemistry from the same university in 2004. Her research activities focus on the development of biomaterials and scaffolds for tissue engineering applications including bone, cartilage, dental, cardiovascular, skin, and the validation of their in vitro and in vivo biocompatibility, functionality and biomechanical characteristics. She applies cutting edge material processing technologies including 3D printing, bioprinting and electrospinning, for the biofabrication of scaffolds, constructs and complex physiological and pathological models. Her work has led to the development of novel orthopaedic and dental biomaterials and medical devices, and tunable biomaterial platforms that control specific physiological processes for tissue engineering and regenerative medicine, using the fundamentals of biological sciences and engineering.

  Dr. Chatzinikolaidou is a Fellow in Biomaterials Science and Engineering FBSE of the International Union of Societies for Biomaterials Science and Engineering (IUS-BSE), elected 2020; International Fellow of Tissue Engineering and Regenerative Medicine FTERM, elected 2023; Fellow of the International Academy for Medical and Biological Engineering FIAMBE, elected 2024; Member of the Steering Committee of the International College of Fellows of BSE for the term 2024-2028, elected 2024; Member of the Governing Council of the International Academy of Medical and Biological Engineering IAMBE for the term 2025-2027, elected 2024; Member of the Council of the European Society for Biomaterials (ESB) for the term 2025-2029, elected 2025. In 2023 she has been elected European Orthopaedic Research Society EORS Ambassador for Greece. She served as vice president of the executive board of the Hellenic Society for Biomaterials in the terms 2015-2018 and 2022-2025. She served as chair of the 28th Conference of the European Society for Biomaterials ESB 2017 held in Athens, and program chair of the TERMIS-EU 2019 conference held in Rhodes in Greece. She has been assigned chair of the 35th Annual Meeting of the European Orthopaedic Research Society (EORS) in 2027 to be held in Chania in Greece. She is an editorial board member in journals related to research on Biomaterials, Tissue Engineering, Biomedical Engineering and Bioprinting. She teaches Biomaterials, Tissue Engineering, Molecular Cell Biology and Biochemistry courses in undergraduate and Master’s programs, and is Erasmus departmental coordinator promoting students and staff mobility.

Nenad Filipovic is former Director of Science Fund of the Republic Serbia and former Rector of University of Kragujevac, Serbia, full Professor at Faculty of Engineering and Head of Center for Bioengineering at University of Kragujevac, Serbia. He was Research Associate at Harvard School of Public Health in Boston, US. His research interests are in the area of computational mechanics, artificial intelligence, biomedical engineering, cardiovascular disease, fluid-structure interaction, biomechanics, bioinformatics, biomedical image processing, medical informatics, multi-scale modeling, software engineering, parallel computing, computational chemistry and bioprocess modeling. He is author and co-author 11 textbooks and 9 monographies, over 400 publications in peer review journals and over 10 software for modeling with finite element method and discrete methods from fluid mechanics and multiphysics. He also leads a number of national and international projects in EU and US in area of bioengineering, artificial intelligence and software development.